Get started
Author

Ioanna Laı̈os

Observed names: I. Laios, Ioanna Laios, Ioanna Laïos, Laios, Ioanna, Laïos, Ioanna
Observed institutions: Centre National de la Recherche Scientifique, University of Mons, Université Libre de Bruxelles, Université de Versailles Saint-Quentin-en-Yvelines, Institut Jules Bordet, Institut Lavoisier de Versailles
OpenAlex ID: A5110107035
SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer
2019 · Bruno V. Sinn, Chunxiao Fu, et al. · npj Breast Cancer · 354
PDF
Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha
2006 · Hye-Sook Seo, David G. DeNardo, et al. · Breast Cancer Research and Treatment · 123
Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cells
2002 · Ana Rivas, Marc Lacroix, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 111
Estrogen Receptor Alpha: Impact of Ligands on Intracellular Shuttling and Turnover Rate in Breast Cancer Cells
2006 · Guy Leclercq, Marc Lacroix, et al. · Current Cancer Drug Targets · 97
PDF
A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines
2010 · Anne Vessières, Cyril Corbet, et al. · Journal of Inorganic Biochemistry · 77
Role of the proteasome in the regulation of estrogen receptor α turnover and function in MCF-7 breast carcinoma cells
2005 · Ioanna Laïos, Fabrice Journé, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 67
PDF
Tamoxifen Derivatives for Delivery of the Antitumoral (DACH)Pt Group: Selective Synthesis by McMurry Coupling, and Biochemical Behaviour
2003 · Siden Top, El Bachir Kaloun, et al. · ChemBioChem · 51
Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells
1996 · Manuel Borrás, Ioanna Laios, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 50
Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens
2003 · Ioanna Laı̈os, Fabrice Journe, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 47
Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells
2007 · Yves Jacquot, Ioanna Laïos, et al. · Bioorganic & Medicinal Chemistry · 43
Estrogenic and anti-estrogenic regulation of estrogen receptor in MCF-7 breast-cancer cells: Comparison of immunocytochemical data with biochemical measurements
1998 · Hye-Sook Seo, Denis Larsimont, et al. · International Journal of Cancer · 37
PDF
Calmodulin-independent, agonistic properties of a peptide containing the calmodulin binding site of estrogen receptor α
2007 · Dominique Gallo, Françoise Jacquemotte, et al. · Molecular and Cellular Endocrinology · 31
PDF
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence
2015 · Michail Ignatiadis, Hatem A. Azim, et al. · JAMA Oncology · 28
PDF
Trophic effect in MCF-7 cells of ERα17p, a peptide corresponding to a platform regulatory motif of the estrogen receptor α—Underlying mechanisms
2008 · Dominique Gallo, Iman Haddad, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 28
PDF
Molecular Basis of Agonistic Activity of ERα17p, a Synthetic Peptide Corresponding to a Sequence Located at the N-Terminal Part of the Estrogen Receptor αLigand Binding Domain
2007 · Dominique Gallo, Yves Jacquot, et al. · Letters in Drug Design & Discovery · 27
Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif—Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells
2009 · Sandrine Bourgoin-Voillard, Dominique Gallo, et al. · Biochemical Pharmacology · 22
PDF
Peptides Targeting Estrogen Receptor Alpha-Potential Applications for Breast Cancer Treatment
2011 · Guy Leclercq, Dominique Gallo, et al. · Current Pharmaceutical Design · 20
Estrogens decrease γ-ray–induced senescence and maintain cell cycle progression in breast cancer cells independently of p53
2007 · Robert-Alain Toillon, Nicolas Magné, et al. · International Journal of Radiation Oncology*Biology*Physics · 20
Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells☆11☆ Contribution of AEK and FJ to the present study is equivalent.
2000 · Abdelhamid El Khissiin, Fabrice Journé, et al. · Steroids · 18
The first organometallic derivative of 11β-ethynylestradiol, a potential high-affinity marker for the estrogen receptor
2000 · Domenico Osella, Giorgio Cavigiolio, et al. · Journal of Organometallic Chemistry · 18
Distinctive Desmoplastic 3D Morphology Associated With BRAFV600E in Papillary Thyroid Cancers
2018 · M. Tarabichi, A. Antoniou, et al. · The Journal of Clinical Endocrinology & Metabolism · 14
PDF
Tumor Banks: A Quality Control Scheme Proposal
2019 · Ligia Craciun, Selim Alex Spinette, et al. · Frontiers in Medicine · 13
PDF
Effect of Fluorination on the Pharmacological Profile of 11β Isomers of Fulvestrant in Breast Carcinoma Cells
2009 · Vangelis Agouridas, Emmanuel Magnier, et al. · Journal of Medicinal Chemistry · 12
Pharmacological Profile of 6,12-Dihydro-3-methoxy-1-benzopyrano[3,4-b][1,4]benzothiazin-6-one, a Novel Human Estrogen Receptor Agonist.
2002 · Yves Jacquot, Anny Cleeren, et al. · Biological and Pharmaceutical Bulletin · 12
PDF
Effects of (R,S)/(S,R)-4,5-bis(2-chloro-4-hydroxyphenyl)-2-imidazolines and (R,S)/(S,R)-2,3-bis(2-chloro-4-hydroxyphenyl)piperazines on estrogen receptor alpha level and transcriptional activity in MCF-7 cells
2007 · Ioanna Laïos, Anny Cleeren, et al. · Biochemical Pharmacology · 10
PDF
Works count: 32
Citation count: 1,355
H-index: 18
I10-index: 26
Year
Topic
Type